A new Covid vaccine has shown to be 89.3% effective against Covid variant in the UK. The vaccine from Novavax is the first that has been used in the UK and found to be effective, said the BBC’s medical editor Fergus Walsh.
The UK’s Prime Minister Borris Johnson welcomed the ‘Good News’ and said the medical regulator will assess the vaccine now.
The UK has so far secured 60 million doses from the company, which will be made in Stockton-on-Tees. The deliveries are expected to be received by the second half of this year after the approval by the Medicines and Healthcare Products Regulatory Agency (MHRA) for the use.
The UK has so far approved three coronavirus vaccines for emergency use – one from AstraZeneca, one by Pfizer and BioNTech, and the third from Moderna.
The jabs by Novavax showed 89.3% efficacy at preventing Covid-19 in participants in its Phase 3 clinical trial in the UK. The clinical trial which enrolled more than 15,000 people aged between 18-84, of whom 27% were older than 65, revealed Novavax.
our latest updates
- Pakistan and Iran Make ‘Significant Progress’ in Talks to End Conflict, Reopen Strait of Hormuz
- ECP Withdraws Senate Seat Vacancy Notification for Murad Saeed
- Petrol Up Rs0.39, Diesel Rs2.40 as Global Oil Prices Remain Elevated
- Moody’s Upgrades Pakistan’s Credit Rating to B3 from Caa1
- PSX Sheds 199 Points, Gold Rallies Rs4,200 per Tola
